Akụkọ
Ịkwalite ịdị irè nke PROTAC: Ọmụmụ ihe nleba anya
Nnyocha e mere n'oge na-adịbeghị anya na Nkwukọrịta Nature na-ekpughe nghọta ndị bụ isi n'ime ụzọ mgbama dị n'ime nke na-agbanwe ịdị irè nke mmebi protein ezubere iche site na iji PROTAC. Nchọpụta a nwere ike imeghe ụzọ maka ọgwụgwọ dị irè maka ọrịa cancer na ọrịa ndị ọzọ.
Ịkwalite ahụike na mgbake: Nlekọta kwa ụbọchị maka ndị ọrịa leukemia
Ịhụ na ahụmihe ọgwụgwọ dị mma ma dị ntụsara ahụ maka ndị ọrịa leukemia gụnyere nlekọta kwa ụbọchị nke ọma, gụnyere ịdị ọcha gburugburu ebe obibi, ịdị ọcha onwe onye, nri na-edozi ahụ, na mmega ahụ kwesịrị ekwesị. Ntuziaka a na-enye ndụmọdụ dị mkpa maka nlekọta dị irè kwa ụbọchị iji kwado mgbake.
Usoro ọgwụgwọ cell NS7CAR-T na-egosi nkwa maka ọgwụgwọ R/R T-ALL/LBL
Nnyocha e mere n'oge na-adịbeghị anya na-egosi ịdị irè na nchekwa nke ọgwụgwọ sel NS7CAR-T n'ịgwọ nlọghachi azụ ma ọ bụ refractory T-cell nnukwu lymphoblastic leukemia (R/R T-ALL) na T-cell lymphoblastic lymphoma (R/R T-LBL). Usoro ọgwụgwọ a na-enye olileanya ọhụrụ maka ndị ọrịa nwere ụdị ọrịa cancer ndị a siri ike.
Nsonaazụ mgbawa nke CD7-Ezubere iche maka CAR-T ọgwụgwọ maka T-ALL na T-LBL
Nnyocha e mere n'oge na-adịbeghị anya na-akọwapụta nsonaazụ na-ekwe nkwa nke CD7-ezubere iche maka ọgwụgwọ antigen receptor (CAR) T cell n'ịgwọ ndị ọrịa nwere nnukwu lymphoblastic leukemia (T-ALL) na T-cell lymphoblastic lymphoma (T-LBL).
Mkpuchi nke Nzukọ Kwa Afọ 2024 ASH na ngosi
Nzukọ Kwa Afọ nke 66 nke American Society of Hematology (ASH) ga-enwe site na December 7-10, 2024, na San Diego Convention Center, na-egosi nyocha na ọganihu dị elu na hematology.
Ịkpọsa 2024 Kwa Afọ Lu Daopei Hematology Forum na August
A ga-eme mmemme afọ iri na abụọ nke Lu Daopei Hematology na Ọgọst 23-24, 2024, na Beijing International Convention Center. Soro anyị maka mkparịta ụka nwere nghọta na ọganihu ọhụrụ na hematology.
Olileanya ọhụrụ na ọgwụgwọ ọrịa kansa: Ọgwụgwọ TIL na-apụta dị ka ihu na-esote
N'agbanyeghị ihe ịma aka na-aga n'ihu na mmepụta ihe na ịzụ ahịa, a na-edozi njedebe ọgwụgwọ CAR-T site na ụzọ ọhụrụ na-ekwe nkwa: ọgwụgwọ Tumor-Infiltrating Lymphocyte (TIL). Ọganihu a na-akpọsa oge ọhụrụ n'ọgụ megide etuto siri ike.
Usoro ọgwụgwọ cellular ọ bụ ọdịnihu nke ọrịa autoimmune?
Ngwọta mgbanwe maka ọrịa cancer nwekwara ike ịgwọ ma tọgharịa usoro ahụ ji alụso ọrịa ọgụ iji nye mgbaghara ogologo oge ma ọ bụ ikekwe ọbụna gwọọ ụfọdụ ọrịa autoimmune.